INSTACAR
LIVE

Serial Number

97790097

Owner

Innovative Cellular Therapeutics, Inc

Attorney

Rhett V. Barney

First Use Date

Apr 22, 2025

Filing Date

Feb 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INSTACAR Trademark

Serial Number: 97790097 • Registration: 8024071

INSTACAR is a trademark filed by Innovative Cellular Therapeutics, Inc on February 10, 2023. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Innovative Cellular Therapeutics, Inc (3 trademarks)

Suite 210, 1405 Research Boulevard,
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

February 10, 2023

Registration Date

November 11, 2025

First Use Anywhere

April 22, 2025

First Use in Commerce

April 22, 2025

Published for Opposition

October 1, 2024

Goods & Services

Cryopreservation of human blood and tissue

Immunotherapy services namely, research and development in the field of cell-based immunotherapy; collection and preservation of biological tissue, blood, and cells, namely, cell culture services for scientific research purposes for others; scientific medical diagnostic services, namely, Blood analysis for scientific or medical research purposes, Blood testing for scientific or medical research purposes, Cell culture and testing services for scientific and research purposes for others; provision of information and data for diagnosis and medical treatment, namely, providing medical and scientific research information in the field of cellular therapies; manipulation of cells for therapeutic purposes, namely, conducting scientific research and development of gene-based medicines and cellular therapies used for medical treatment purposes; Scientific research in the nature of conducting clinical trials for others in relation to immunotherapy pharmaceutical preparations and drugs for the treatment of cancer and autoimmune diseases; Scientific research in the nature of conducting clinical trials for others in relation to cellular therapy pharmaceutical preparations and drugs for the treatment of genetic disorders and degenerative diseases

Medical diagnostic services, namely, Testing for medical diagnostic or treatment purposes using blood and cell samples; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services relating to the removal, treatment and processing of human blood

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 22, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 22, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 20, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 16, 2025 AITU
USE AMENDMENT FILED
May 13, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
May 13, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2024 CRFA
ASSIGNED TO LIE
Jul 22, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 2, 2024 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Feb 2, 2024 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Feb 2, 2024 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Feb 2, 2024 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Feb 2, 2024 CPEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2023 NWOS
NEW APPLICATION ENTERED
Feb 14, 2023 NWAP